IDScan is offering free credit monitoring and ID protection after leaking driver's licenses27m ago Google brings Gemini for desktop app to Windows37m ago How to watch the Flame Fatales 2026 speedrunning marathon41m ago Amazon makes its agentic AI platform Quick generally available for desktop on Windows and macOS50m ago Ant International, Visa, Mastercard Align on AI Agent Verification Rules50m ago Panic builds over bankrupt Spirit’s looming data sale to Google52m ago Wall Street already loves ChatGPT. Now OpenAI is doubling down.2h ago BNP says AI borrowing will end the credit bull market, and it is lending to AI too1h ago Anthropic reveals rogue AI agents hate CAPTCHAs, just like you1h ago Cognition Adds Dioxus Team to Advance Devin Coding Agent1h ago Peter Thiel-Backed AI Startup Cognition Raises Funds at $48 Billion Valuation1h ago Anthropic Details Disrupted Claude Misuse Across Seven Harm Areas1h ago OpenAI Releases GPT-6 Astra for Coding and Computer Use1h ago The AI You Didn't Know You Bought1h ago

IDScan is offering free credit monitoring and ID protection after leaking driver's licenses27m ago Google brings Gemini for desktop app to Windows37m ago How to watch the Flame Fatales 2026 speedrunning marathon41m ago Amazon makes its agentic AI platform Quick generally available for desktop on Windows and macOS50m ago Ant International, Visa, Mastercard Align on AI Agent Verification Rules50m ago Panic builds over bankrupt Spirit’s looming data sale to Google52m ago Wall Street already loves ChatGPT. Now OpenAI is doubling down.2h ago BNP says AI borrowing will end the credit bull market, and it is lending to AI too1h ago Anthropic reveals rogue AI agents hate CAPTCHAs, just like you1h ago Cognition Adds Dioxus Team to Advance Devin Coding Agent1h ago Peter Thiel-Backed AI Startup Cognition Raises Funds at $48 Billion Valuation1h ago Anthropic Details Disrupted Claude Misuse Across Seven Harm Areas1h ago OpenAI Releases GPT-6 Astra for Coding and Computer Use1h ago The AI You Didn't Know You Bought1h ago

Antiverse raises $9.3M Series A to scale AI-driven antibody discovery from Cardiff

The Next WebPublished Mar 3, 2026

Antiverse secured $9.3 million in Series A funding to advance its AI-driven platform for discovering antibodies, aiming to accelerate drug development from its base in Cardiff.

#antibody-discovery #antiverse #cardiff #drug-development #series-a-funding

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources20h ago

Healthcare5 min read

Digital Finance Needs A New Kind Of Identity For AI-Driven Economies

Forbes2h ago

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News3h ago